Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (111-120 of 787) with videos related to

Pageof 79
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2011
Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case reportPierre Peterlin, Thierry Ponge, Nicolas Blin, et al.
Haematologica|June 1, 2005
CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severityRégis Bataille, Nelly Robillard, Hervé Avet-Loiseau, et al.
Cancer|November 20, 2013
The effects of bortezomib on bone disease in patients with multiple myelomaMohamad Mohty, Florent Malard, Bilal Mohty, et al.
Cancer Letters|October 5, 2016
Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosisPatricia Gomez-Bougie, Maxime Halliez, Philippe Moreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
HLA-G gene repression is reversed by demethylationPhilippe Moreau, Gael Mouillot, Philippe Rousseau, et al.
Leukemia|December 22, 2018
Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurementsThomas Dejoie, Jill Corre, Helene Caillon, et al.
Molecular Immunology|August 7, 2007
Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cellsChristine Guillard, Inès Zidi, Céline Marcou, et al.
Clinical Trials (London, England)|July 4, 2013
Modeling of experts' divergent prior beliefs for a sequential phase III clinical trialMarion Moatti, Sarah Zohar, Thierry Facon, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2019
Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple MyelomaHélène Caillon, Hervé Avet-Loiseau, Michel Attal, et al.
Journal of the American Chemical Society|July 17, 2013
Synergistic effect in carbon coated LiFePO4 for high yield spontaneous grafting of diazonium salt. Structural examination at the grain agglomerate scaleLénaïc Madec, Donatien Robert, Philippe Moreau, et al.
Pageof 79

Showing results (111-120 of 787) with videos related to

Sort By:
Pageof 79
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2011
Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case reportPierre Peterlin, Thierry Ponge, Nicolas Blin, et al.
Haematologica|June 1, 2005
CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severityRégis Bataille, Nelly Robillard, Hervé Avet-Loiseau, et al.
Cancer|November 20, 2013
The effects of bortezomib on bone disease in patients with multiple myelomaMohamad Mohty, Florent Malard, Bilal Mohty, et al.
Cancer Letters|October 5, 2016
Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosisPatricia Gomez-Bougie, Maxime Halliez, Philippe Moreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
HLA-G gene repression is reversed by demethylationPhilippe Moreau, Gael Mouillot, Philippe Rousseau, et al.
Leukemia|December 22, 2018
Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurementsThomas Dejoie, Jill Corre, Helene Caillon, et al.
Molecular Immunology|August 7, 2007
Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cellsChristine Guillard, Inès Zidi, Céline Marcou, et al.
Clinical Trials (London, England)|July 4, 2013
Modeling of experts' divergent prior beliefs for a sequential phase III clinical trialMarion Moatti, Sarah Zohar, Thierry Facon, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2019
Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple MyelomaHélène Caillon, Hervé Avet-Loiseau, Michel Attal, et al.
Journal of the American Chemical Society|July 17, 2013
Synergistic effect in carbon coated LiFePO4 for high yield spontaneous grafting of diazonium salt. Structural examination at the grain agglomerate scaleLénaïc Madec, Donatien Robert, Philippe Moreau, et al.
Pageof 79